Stefan O Ciurea

39PUBLICATIONS
104CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jun 09, 2026
Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial.

|Dec 06, 2025
Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis.

Chalothorn Wannaphut, Piyatida Chumnumsiriwath, Stefan O Ciurea

|Sep 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.

Stephanie J Lee, Brent Logan, Mary M Horowitz

|Jan 08, 2025
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation.

Piyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin

|Oct 22, 2024
Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience.

Benjamin J Lee, Shawn P Griffin, Jean Doh

|Oct 12, 2024
Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.

Benjamin J Lee, Jenny Liu, Shawn P Griffin

Pageof 7

Frequent Collaborators

11 joint publications

Piyanuch Kongtim

10 joint publications

Benjamin J Lee

8 joint publications

Shawn P Griffin

6 joint publications

Jean Doh